Subgroup analyses were performed on the primary outcome measures : the mean change in the Montgomery-sberg Depression Rating Scale ( MADRS ) total score from the end of selective serotonin reuptake inhibitor ( SSRI ) / serotonin norepinephrine reuptake inhibitor ( SNRI ) treatment to the end of the randomized treatment .